DPYSL2 and Hyperglycemia: The finding of higher levels of inactive pCRMP2 in CRC-DM patients (Figure 2C) and mice (compared to colitis-CRC, Figure 6D) indicates that hyperglycemia downregulates CRMP2 and supports the association between glucose-mediated CRMP2 with CRC tumorigenesis [15].